期刊文献+

GST-颗粒溶解素融合蛋白的纯化及其抗菌活性分析 被引量:1

Purification and antibacterial activity analysis of GST-granulysin fusion protein
下载PDF
导出
摘要 目的:纯化大肠埃希菌表达的GST-颗粒溶解素融合蛋白,并分析其体外抗菌活性。方法:将IPTG诱导处理后的细菌破碎,分离含有可溶性GST-颗粒溶解素融合蛋白的细菌裂解液,并通过GSH-琼脂糖珠亲和层析柱纯化。同时采用MTT法分析该纯化蛋白的抗菌活性。结果:GST-颗粒溶解素融合蛋白能以可溶性形式在大肠埃希菌中表达,采用亲和层析法可获得分子量为44kDa的单一蛋白条带。经抗菌活性分析,表明纯化产物对金黄色葡萄球菌和甲型溶血性链球菌具有显著抑制作用,而对伤寒沙门菌和大肠埃希菌BL21的抗菌活性不明显。结论:成功纯化GST-颗粒溶解素融合蛋白,该蛋白对革兰阳性菌具有高效抗菌活性。 Objective: To purify GST-granulysin fusion protein expressed in E. coli and identify its antibacterial activity in vitro. Methods:E. coli was sonicated after it was induced by IPTG, and GST-granulysin fusion protein was separated from the soluble extract. The fusion protein was purified by affinity chromatography with glutathione agarose. Its bactericidal activity was analysed by MTT assay. Results: Expression of GST-granulysin in E. coli was detected by SDS-page methods. After affinity chromatography, a single protein band at about molecular weight 44 kDa was obtained. The result of bactericidal activity analysis indicated that it showed potent antibacterial activity against Staphylococcus aureus and Streptococcus sanguis, but it showed weaker antibacterial activity against Salmonella enterica and E. coli BI21. Conclusions :The GST-granulysin fusion protein was successfully purified, and it exhibits effective bactericidal activity against gram positive bacteria.
出处 《蚌埠医学院学报》 CAS 2007年第3期265-267,共3页 Journal of Bengbu Medical College
基金 安徽省自然科学基金资助项目(050430603) 安徽省教育厅自然科学研究资助项目(2006kj122zc)
关键词 大肠埃希菌 颗粒溶解素 融合表达 纯化 抗菌作用 Escherichia coli granulysin fusion expression purification bactericide
  • 相关文献

参考文献9

二级参考文献19

  • 1薛松 Edeman A Thorbecke GJ.介绍一种用颜色显示法测细胞的生长及增殖[J].北京医科大学学报,1987,19(20):125-125.
  • 2Pena SV, Hanson DA, Can- BA, et al. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to maall, lytic, granule proteins[J].J Immunol, 1997,158(6) :2680-2688.
  • 3Jongstra J,Schall TJ, Dyer BJ, et al. The isolation and sequence of a novel gene from a human functional T cell line[J] .J Exp Med,1987,165(3) :601 --614.
  • 4Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin [ J ]. Science,1998,282(5 386) : 121 - 125.
  • 5Ernst WA,Thoma-Uszvnski S,Teitelbaum R, et al. Granulysin,a T Cell product, Kills bacteria by altering membrane permeability[J].J Immunol,2000,165(12):7102-7108.
  • 6Gamen S,Hanson DA,Kaspar A, et al. Gramalysin-induced apoptosis.I. Involvment of at least two distinct pathways[J ]. J Immunol,1998,161(4):1758-1764.
  • 7Sarwal MM, Jani A, Chang S, et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation[ J ]. Hum Immunol, 2001,62 ( 1 ) : 21 -- 31.
  • 8Mosmaan T.Colorimetric assay cellular growth and survival:Application to proliferation and cytotoxityassays[J].JImmunolMethods,1983;65(1):55
  • 9李影林.中华医学检验全书(下卷)[M].北京:人民卫生出版社,1997;2212
  • 10金冬雁 黎孟枫译.分子克隆实验指南 第2版[M].北京:科学出版社,1992.49~56.

共引文献35

同被引文献14

  • 1Ando T, Yamashiro T, Takita-Sonoda Y, et al. Construction of human Fab library and isolation of monoclonal Fabs with rabies virus-neutralizing ability E J]. Mierobiol Immunol, 2005, 49 311-322.
  • 2Benmansour A H, Leblosis H, Couln P. Antigenieity of rabies virus glycoprotein[J]. J Virol, 1991,65 : 4198 -4203.
  • 3Conzelmann K K, Cox J H, Schneider L G, et al. Molecular clo- ning and complete nucleotide sequence of the attenuated rabies virus SAD-B19[J]. Virology, 1990, 175(2) :485-489.
  • 4Dietzschold B, Rupprecht C E, Tollis M, et al. Antigenic diver- sity of the glycoprotein and nucleocapsid proteins of rabies and rabies related virus: Implication for epidemiology and control of rabies[J]. Reviews of Infectious Diseases, 1988, 10:785.
  • 5Dodet B, Meslin F X, Heseltine E. Rabies control in Asia[M]. John Libbey Eurotext, Montrouge,2001.
  • 6Liu X J, Lin H, Tang Q, et al. Characterization of a human an- tibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine[J]. PLoS One, 2011, 6(5) : e19848.
  • 7Luo T R, Minamoto N, Hishida M, et al. Antigenic and func- tional analyses of glycoprotein of rabies virus using monoelonal antibodies[J]. Microbiol Immunol, 1998, 42(3) 187-193.
  • 8Tordo N, Poch O, Ermine A, et al. Completion of rabies ge- norne sequence determination: Highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses[J]. Virology, 1988,165:565-576.
  • 9World Health Organization. WHO expert consultation on rabie [S]. Geneva, 2005.
  • 10Zhu J H, Wang J L, Cai B, et al. Immunogenieity and relative attenuation of different vaeeine-rabies reeombinants [J]. Arch Virol, 1996, 141:1055-1065.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部